Other Stories

Full Video

S. Korea to allow more general hospitals to prescribe oral COVID-19 pills; 128,714 new infections reported on Friday Updated: 2022-08-12 17:24:58 KST

South Korea today saw a decline in new cases of COVID-19, but it's still well above a hundred thousand.
The health authorities have decided to allow more hospitals to prescribe COVID pills to boost access to them, especially for older people.
Our Han Seong-woo has the details.

South Korea reported 128,714 new cases of COVID-19 on Friday
The daily tally declined for the second day in a row but has remained above 100-thousand since Tuesday.
464 of the new infections were from overseas.
The Korea Disease Control and Prevention Agency also confirmed 58 more deaths raising the death toll to just under 25-thousand five-hundred.
The number of seriously ill patients, meanwhile, rose to 453, up 35 from the day before.
In response to the recent resurgence, the South Korean government early this month purchased an extra load of oral COVID-19 treatments enough for roughly 940-thousand people mostly the Paxlovid pill.
They'll be distributed across the nation over the next few months.
Health authorities are also planning to allow smaller general hospitals, in addition to larger ones and so-called "one-stop" medical centers, to prescribe the oral medication.
The aim is to distribute more of the pills to patients in the high-risk groups, particularly those over sixty years old.
Authorities also say they will keep a closer watch on whether prevention measures are being stuck to at large-scale summer concerts and festivals.
The KDCA said Thursday that it took an average of 154 to 165 days for a COVID-19 patient to be reinfected in July, much shorter than the average of 229 days counted for reinfected patients in June.
It also found that those aged 17 or under and unvaccinated people were more susceptible to reinfection.
Han Seong-woo, Arirang News.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.